Didem Karakaş

836 total citations
30 papers, 617 citations indexed

About

Didem Karakaş is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Didem Karakaş has authored 30 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Didem Karakaş's work include Cancer Cells and Metastasis (10 papers), Metal complexes synthesis and properties (6 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Didem Karakaş is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Metal complexes synthesis and properties (6 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Didem Karakaş collaborates with scholars based in Türkiye, United States and Egypt. Didem Karakaş's co-authors include Engı̇n Ulukaya, Bülent Özpolat, Ferda Arı, Buse Cevatemre, Nazlıhan Aztopal, Veysel T. Yılmaz, Nádia Ribeiro, Ceyda Açılan, João Costa Pessoa and Zelal Adıgüzel and has published in prestigious journals such as Clinical Cancer Research, European Journal of Cancer and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Didem Karakaş

27 papers receiving 610 citations

Peers

Didem Karakaş

ONCOL

TOXIC

Swayamsiddha Kar India

Jo‐Anne de la Mare South Africa

Aykut Özgür Türkiye

Yunxue Zhao China

Fujun Dai China

David Vásquez Chile

Guangyue Li China

Bijesh Kumar Biswal India

Saswati Banerjee United States

Victor V. Tatarskiy Russia

Swayamsiddha Kar India

Didem Karakaş

635 ×1.9

126 ×0.7

ONCOL

168 ×1.1

93 ×0.7

28 ×0.5

TOXIC

Citations per year, relative to Didem Karakaş Didem Karakaş (= 1×) peers Swayamsiddha Kar

Countries citing papers authored by Didem Karakaş

Since Specialization

Citations

This map shows the geographic impact of Didem Karakaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didem Karakaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didem Karakaş more than expected).

Fields of papers citing papers by Didem Karakaş

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didem Karakaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didem Karakaş. The network helps show where Didem Karakaş may publish in the future.

Co-authorship network of co-authors of Didem Karakaş

This figure shows the co-authorship network connecting the top 25 collaborators of Didem Karakaş. A scholar is included among the top collaborators of Didem Karakaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didem Karakaş. Didem Karakaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karakaş, Didem, Ahmed A. Ashour, Hamada A. Mokhlis, et al.. (2025). eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment. Cell Death and Disease. 16(1). 501–501.

Karakaş, Didem, Nazlıhan Aztopal, Merve Erkısa, et al.. (2025). Cancer-Stimulated Schwann Cells Exacerbate Pancreatic Cancer Aggressiveness via Exosomal Signaling. Pancreatology. 25(7). 1275–1275.

Aksoy, Seçil Ak, et al.. (2024). Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models. Seminars in Cancer Biology. 109. 10–24. 4 indexed citations

Moretti, Alessandra, Didem Karakaş, Helmut Frieß, et al.. (2024). Protocol for whole-mount immunofluorescence staining of ECM gel-embedded innervated pancreatic organoids. STAR Protocols. 5(2). 103132–103132. 2 indexed citations

Karakaş, Didem, et al.. (2022). Evidence for heterogeneity in response to treatment in mammary tumors of dogs as happens in humans. Veterinary Research Communications. 47(1). 111–120. 1 indexed citations

Ulukaya, Engı̇n, Didem Karakaş, & Konstantinos Dimas. (2021). Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients. Medicina. 57(6). 636–636. 12 indexed citations

Görür, Ayşegül, Recep Bayraktar, Cristina Ivan, et al.. (2021). ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer. Molecular Therapy — Nucleic Acids. 23. 930–943. 36 indexed citations

Karakaş, Didem & Bülent Özpolat. (2020). Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. Journal of Molecular Medicine. 98(6). 775–787. 30 indexed citations

Erkısa, Merve, Didem Karakaş, & Engı̇n Ulukaya. (2019). Cancer Stem Cells: Root of the Evil. Critical Reviews™ in Oncogenesis. 24(1). 69–87. 12 indexed citations

10.

Karakaş, Didem, et al.. (2019). A novel 1,4-naphthoquinone-derived compound induces apoptotic cell death in breast cancer cells. TURKISH JOURNAL OF BIOLOGY. 43(4). 256–263. 10 indexed citations

11.

Karakaş, Didem, Buse Cevatemre, Arzu Yılmaztepe Oral, Veysel T. Yılmaz, & Engı̇n Ulukaya. (2019). Unfolded Protein Response is Involved in Trans-Platinum (II) Complex-Induced Apoptosis in Prostate Cancer Cells via ROS Accumulation. Anti-Cancer Agents in Medicinal Chemistry. 19(9). 1184–1195. 2 indexed citations

12.

Bayraktar, Recep, Cristina Ivan, Emine Bayraktar, et al.. (2018). Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion. Clinical Cancer Research. 24(17). 4225–4241. 74 indexed citations

13.

Karakaş, Didem, et al.. (2017). Cytotoxic and apoptotic effects of the combination of palladium (II) 5,5-diethylbarbiturate complex with bis(2-pyridylmethyl)amine and curcumin on non small lung cancer cell lines. Bioorganic & Medicinal Chemistry. 25(5). 1717–1723. 27 indexed citations

14.

Karakaş, Didem, Ferda Arı, & Engı̇n Ulukaya. (2017). The MTT viability assay yields strikingly false-positive viabilities although the cells are killed by some plant extracts. TURKISH JOURNAL OF BIOLOGY. 41(6). 919–925. 73 indexed citations

15.

Cevatemre, Buse, Merve Erkısa, Nazlıhan Aztopal, et al.. (2017). A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. Pharmacological Research. 129. 500–514. 66 indexed citations

16.

Açılan, Ceyda, Buse Cevatemre, Zelal Adıgüzel, et al.. (2016). Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(2). 218–234. 77 indexed citations

17.

Açılan, Ceyda, Buse Cevatemre, Zelal Adıgüzel, et al.. (2016). Validation data supporting the characterization of novel copper complexes as anticancer agents. Data in Brief. 9. 1160–1174. 4 indexed citations

18.

Aztopal, Nazlıhan, Didem Karakaş, Buse Cevatemre, et al.. (2016). A trans-platinum(II) complex induces apoptosis in cancer stem cells of breast cancer. Bioorganic & Medicinal Chemistry. 25(1). 269–276. 25 indexed citations

19.

Karakaş, Didem, Buse Cevatemre, Nazlıhan Aztopal, et al.. (2015). Addition of niclosamide to palladium(II) saccharinate complex of terpyridine results in enhanced cytotoxic activity inducing apoptosis on cancer stem cells of breast cancer. Bioorganic & Medicinal Chemistry. 23(17). 5580–5586. 35 indexed citations

20.

Karakaş, Didem, Nazlıhan Aztopal, Buse Cevatemre, et al.. (2014). 313: Breast cancer stem cells are more resistant than parental cells to a novel palladium (II) saccharinate complex. European Journal of Cancer. 50. S74–S75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact